Retention rate of acalabrutinib in a non-interventional setting

Trial Identifier: D8224R00001
Sponsor: AstraZeneca
NCTID:: NCT05645172
Start Date: December 2022
Primary Completion Date: April 2026
Study Completion Date: April 2026

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Germany Hannover, Germany, 30161
Germany Leipzig, Germany, 4289
Germany Munchen, Germany, 81377
Germany, Germany Aschaffenburg, Germany, Germany, 63739
Germany, Germany Zittau, Germany, Germany, 2763